CARGO Therapeutics Inc. C... (CRGX)
CARGO Therapeutics Common Stock Statistics
Share Statistics
CARGO Therapeutics Common Stock has 46.05M shares outstanding. The number of shares has increased by 16.93% in one year.
Shares Outstanding | 46.05M |
Shares Change (YoY) | 16.93% |
Shares Change (QoQ) | 0.27% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 29.8M |
Failed to Deliver (FTD) Shares | 450.21K |
FTD / Avg. Volume | 40.42% |
Short Selling Information
The latest short interest is 7.21M, so 15.67% of the outstanding shares have been sold short.
Short Interest | 7.21M |
Short % of Shares Out | 15.67% |
Short % of Float | 22.49% |
Short Ratio (days to cover) | 23.98 |
Valuation Ratios
The PE ratio is -3.87 and the forward PE ratio is -3.4. CARGO Therapeutics Common Stock's PEG ratio is -0.07.
PE Ratio | -3.87 |
Forward PE | -3.4 |
PS Ratio | 0 |
Forward PS | 0.7 |
PB Ratio | 1.8 |
P/FCF Ratio | -4.5 |
PEG Ratio | -0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CARGO Therapeutics Inc. Common Stock.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.79, with a Debt / Equity ratio of 0.08.
Current Ratio | 13.79 |
Quick Ratio | 13.79 |
Debt / Equity | 0.08 |
Total Debt / Capitalization | 7.55 |
Cash Flow / Debt | -4.75 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.46% and return on capital (ROIC) is -48.09%.
Return on Equity (ROE) | -0.46% |
Return on Assets (ROA) | -0.4% |
Return on Capital (ROIC) | -48.09% |
Revenue Per Employee | $0 |
Profits Per Employee | $-1,003,005.99 |
Employee Count | 167 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -81.36% in the last 52 weeks. The beta is 1.64, so CARGO Therapeutics Common Stock's price volatility has been higher than the market average.
Beta | 1.64 |
52-Week Price Change | -81.36% |
50-Day Moving Average | 5.67 |
200-Day Moving Average | 14.62 |
Relative Strength Index (RSI) | 42.26 |
Average Volume (20 Days) | 1.11M |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -187.37M |
Net Income | -167.5M |
EBITDA | -187.37M |
EBIT | n/a |
Earnings Per Share (EPS) | -3.72 |
Balance Sheet
The company has 64.38M in cash and 29.43M in debt, giving a net cash position of 34.95M.
Cash & Cash Equivalents | 64.38M |
Total Debt | 29.43M |
Net Cash | 34.95M |
Retained Earnings | -312.65M |
Total Assets | 414.05M |
Working Capital | 319.99M |
Cash Flow
In the last 12 months, operating cash flow was -139.74M and capital expenditures -4.45M, giving a free cash flow of -144.19M.
Operating Cash Flow | -139.74M |
Capital Expenditures | -4.45M |
Free Cash Flow | -144.19M |
FCF Per Share | -3.21 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRGX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -89.42% |
FCF Yield | -75.26% |
Analyst Forecast
The average price target for CRGX is $4, which is -3.8% lower than the current price. The consensus rating is "Hold".
Price Target | $4 |
Price Target Difference | -3.8% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Scores
Altman Z-Score | 0.64 |
Piotroski F-Score | 1 |